BIM
TARO

Bogle Investment Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Bogle Investment Management’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-5,709
Closed -$349K – 444
2020
Q1 		$349K Buy
+5,709
New +$423K 0.04% 227
2014
Q2 		– Sell
-9,272
Closed -$1.03M – 397
2014
Q1 		$1.03M Buy
+9,272
New +$1.01M 0.07% 267

Other funds holding TARO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Bogle Investment Management's TARO Position: Q2 2020 in Review

Bogle Investment Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2020, closing a stake of 5,709 shares — an estimated $349K sold.

Bogle Investment Management first reported a position in TARO in Q1 2014 and held it in 2 quarters. The position peaked at $1.03M in Q1 2014. 84 funds tracked by Wall St. Rank hold TARO as of Q2 2020.

  • Bogle Investment Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2020 after selling out during the quarter.
  • Bogle Investment Management sold 5,709 Taro Pharmaceutical Industries Ltd. shares in Q2 2020, an estimated $349K.
  • Bogle Investment Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2014 and held it in 2 quarters.
  • Bogle Investment Management's Taro Pharmaceutical Industries Ltd. position peaked at $1.03M in Q1 2014.
  • 84 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2020.

Based on Bogle Investment Management's 13F filing for Q2 2020, filed 13 Aug 2020.